Gene regulatory network study of rheumatoid arthritis in single-cell chromatin landscapes of peripheral blood mononuclear cells
Modern Rheumatology · 2023
DOI: 10.1093/mr/roac072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Cantong Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Leukocytes, Mononuclear, Chromatin Immunoprecipitation Sequencing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Science FoundationNational Science Foundation, Development Programme of Guangdong Province, Sanming Project of Medicine in Shenzhen.
Abstract (Originalsprache)
Objectives
Assays for transposase-accessible chromatin with single-cell sequencing (scATAC-seq) contribute to the progress in epigenetic studies. The purpose of our project was to discover the transcription factors (TFs) that were involved in the pathogenesis of rheumatoid arthritis (RA) at a single-cell resolution using epigenetic technology.
Methods
Peripheral blood mononuclear cells of seven RA patients and seven natural controls were extracted nuclei suspensions for library construction. Subsequently, scATAC-seq was performed to generate a high-resolution map of active regulatory DNA for bioinformatics analysis.
Results
We obtained 22 accessible chromatin patterns. Then, 10 key TFs were involved in RA pathogenesis by regulating the activity of mitogen-activated protein kinase. Consequently, two genes (PTPRC and SPAG9) regulated by 10 key TFs were found, which may be associated with RA disease pathogenesis, and these TFs were obviously enriched in RA patients (P < .05, fold change value > 1.2). With further quantitative polymerase chain reaction validation on PTPRC and SPAG9 in monocytes, we found differential expression of these two genes, which were regulated by eight TFs [ZNF384, HNF1B, DMRTA2, MEF2A, NFE2L1, CREB3L4 (var. 2), FOSL2::JUNB (var. 2), and MEF2B], showing highly accessible binding sites in RA patients.
Conclusions
These findings demonstrate the value of using scATAC-seq to reveal transcriptional regulatory variation in RA-derived peripheral blood mononuclear cells, providing insights into therapy from an epigenetic perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, Guangdong, China.
- Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, Germany.
- College of Natural Science, University of Texas at Austin, Austin, TX, USA.
Förderung
- National Science FoundationNational Science Foundation
- Development Programme of Guangdong Province
- Sanming Project of Medicine in Shenzhen
- Shenzhen Key Medical Discipline Construc-tion Fund
- Guangxi Key Laboratory of Metabolic Diseases Research
Zitieren
APA
Zhang, C., Hong, X., Yu, H., Xu, H., Qiu, X., Cai, W., Hocher, B., Dai, W., Tang, D., Liu, D., & Dai, Y. (2023). Gene regulatory network study of rheumatoid arthritis in single-cell chromatin landscapes of peripheral blood mononuclear cells. Modern Rheumatology. https://doi.org/10.1093/mr/roac072
Vancouver
Zhang C, Hong X, Yu H, Xu H, Qiu X, Cai W, et al. Gene regulatory network study of rheumatoid arthritis in single-cell chromatin landscapes of peripheral blood mononuclear cells. Modern Rheumatology. 2023. doi:10.1093/mr/roac072
BibTeX
@article{Zhang2023,
author = {Zhang, Cantong and Hong, Xiaoping and Yu, Haiyan and Xu, Huixuan and Qiu, Xiaofen and Cai, Wanxia and Hocher, Berthold and Dai, Weier and Tang, Donge and Liu, Dongzhou and Dai, Yong},
title = {Gene regulatory network study of rheumatoid arthritis in single-cell chromatin landscapes of peripheral blood mononuclear cells},
journal = {Modern Rheumatology},
year = {2023},
doi = {10.1093/mr/roac072}
}
EUVIMED